Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eli Gilboa

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in MiceTal Gefen, Iris Castro, Darija Muharemagic, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Vaccination against neoantigens induced in cross-priming cDC1 in vivoEmily S Clark, Ana Paula Benaduce, Wasif N Khan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
4-1BB Aptamer-Based Immunomodulation Enhances the Therapeutic Index of Radiation Therapy in Murine Tumor ModelsAna Paula Benaduce, Randall Brenneman, Brett Schrand, et al.
Oncoimmunology|April 11, 2018
Potentiating tumor immunity using aptamer-targeted RNAi to render CD8<sup>+</sup> T cells resistant to TGFβ inhibitionYvonne Puplampu-Dove, Tal Gefen, Anugraha Rajagopalan, et al.
Nature Reviews. Drug Discovery|September 8, 2018
An RNA toolbox for cancer immunotherapyFernando Pastor, Pedro Berraondo, Iñaki Etxeberria, et al.
Nucleic Acids Research|April 15, 2015
Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discoveryJan Hoinka, Alexey Berezhnoy, Phuong Dao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapyMartin Fassnacht, Jaewoo Lee, Caterina Milazzo, et al.
European Journal of Immunology|July 7, 2007
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral AgNada M Melhem, Xiang Dong Liu, David Boczkowski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytesXinsheng Liao, Yongqing Li, Chiara Bonini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturationSmita Nair, Catherine McLaughlin, Alon Weizer, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Molecular Therapy : the Journal of the American Society of Gene Therapy|August 13, 2017
A TIM-3 Oligonucleotide Aptamer Enhances T Cell Functions and Potentiates Tumor Immunity in MiceTal Gefen, Iris Castro, Darija Muharemagic, et al.
Cancer Immunology, Immunotherapy : CII|January 17, 2024
Vaccination against neoantigens induced in cross-priming cDC1 in vivoEmily S Clark, Ana Paula Benaduce, Wasif N Khan, et al.
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
4-1BB Aptamer-Based Immunomodulation Enhances the Therapeutic Index of Radiation Therapy in Murine Tumor ModelsAna Paula Benaduce, Randall Brenneman, Brett Schrand, et al.
Oncoimmunology|April 11, 2018
Potentiating tumor immunity using aptamer-targeted RNAi to render CD8<sup>+</sup> T cells resistant to TGFβ inhibitionYvonne Puplampu-Dove, Tal Gefen, Anugraha Rajagopalan, et al.
Nature Reviews. Drug Discovery|September 8, 2018
An RNA toolbox for cancer immunotherapyFernando Pastor, Pedro Berraondo, Iñaki Etxeberria, et al.
Nucleic Acids Research|April 15, 2015
Large scale analysis of the mutational landscape in HT-SELEX improves aptamer discoveryJan Hoinka, Alexey Berezhnoy, Phuong Dao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2005
Induction of CD4(+) and CD8(+) T-cell responses to the human stromal antigen, fibroblast activation protein: implication for cancer immunotherapyMartin Fassnacht, Jaewoo Lee, Caterina Milazzo, et al.
European Journal of Immunology|July 7, 2007
Robust CD4+ and CD8+ T cell responses to SIV using mRNA-transfected DC expressing autologous viral AgNada M Melhem, Xiang Dong Liu, David Boczkowski, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2004
Transfection of RNA encoding tumor antigens following maturation of dendritic cells leads to prolonged presentation of antigen and the generation of high-affinity tumor-reactive cytotoxic T lymphocytesXinsheng Liao, Yongqing Li, Chiara Bonini, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 25, 2003
Injection of immature dendritic cells into adjuvant-treated skin obviates the need for ex vivo maturationSmita Nair, Catherine McLaughlin, Alon Weizer, et al.
Pageof 8